Update on Relapsed/Refractory CLL/SLL Webinar

Program Overview:

Overview of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Considering Second- and Third-Line Treatment Options
Update on Clinical Trials
Understanding Minimal Residual Disease (MRD) Status
Questions and Answers